BG Medicine, Inc. Obtains CE Mark and Files 510(k) for Expanded BGM Galectin-3 ... MarketWatch (press release) The blood test was cleared by the FDA in November 2010 and is currently indicated for use in patients with chronic heart failure who are at increased risk for hospitalizations or death based on elevated levels of galectin-3. Subject to FDA clearance, ... BG Medicine Announces Publication of First Study on Use of Galectin-3 in ... BG Medicine Announces Fiscal 2012 First Quarter Results BG MEDICINE, INC. : Announces Availability of Galectin-3 Diagnostic Testing ... |
